alfuzosin has been researched along with Cancer of Prostate in 7 studies
alfuzosin: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "The adrenergic alpha-1 and -2 adrenoceptors in six human hypertrophied prostatic adenomas were measured in the saturation experiment using 3H-prazosin and 3H-yohimbine." | 3.68 | [Comparison of selective alpha-1 blockades for alpha-receptors in human hypertrophied prostatic adenomas]. ( Kondo, S; Morita, T, 1992) |
| "Treatment with prazosin (30 μM) altered the expression of several cell stress-related proteins: elevating phospho-p38α and reducing S6 kinase in both cell lines." | 1.43 | Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines. ( Anoopkumar-Dukie, S; Chess-Williams, R; Forbes, A; McDermott, C, 2016) |
| " A history and several investigations were conducted to determine the etiology of this adverse event." | 1.32 | Priapism as a possible acute side effect of radical radiotherapy for prostate cancer. ( Hayter, C; Lomaga, MA, 2004) |
| "5." | 1.29 | Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract. ( Gautier, E; Hicks, PE; Langer, SZ; Lechaire, J; Lefèvre-Borg, F; Manoury, P; O'Connor, SE; Pierre, F; Pimoule, C; Schoemaker, H, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forbes, A | 1 |
| Anoopkumar-Dukie, S | 1 |
| Chess-Williams, R | 1 |
| McDermott, C | 1 |
| Murtola, TJ | 1 |
| Kujala, PM | 1 |
| Tammela, TL | 1 |
| Lomaga, MA | 1 |
| Hayter, C | 1 |
| Liu, SJ | 1 |
| Xu, KX | 1 |
| Wang, XF | 1 |
| Hou, SK | 1 |
| Wang, YC | 1 |
| Magri, V | 1 |
| Trinchieri, A | 1 |
| Montanari, E | 1 |
| Del Nero, A | 1 |
| Mangiarotti, B | 1 |
| Zirpoli, P | 1 |
| de Eguileor, M | 1 |
| Marras, E | 1 |
| Ceriani, I | 1 |
| Vral, A | 1 |
| Perletti, G | 1 |
| Lefèvre-Borg, F | 1 |
| O'Connor, SE | 1 |
| Schoemaker, H | 1 |
| Hicks, PE | 1 |
| Lechaire, J | 1 |
| Gautier, E | 1 |
| Pierre, F | 1 |
| Pimoule, C | 1 |
| Manoury, P | 1 |
| Langer, SZ | 1 |
| Morita, T | 1 |
| Kondo, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized, Open-Labeled Study of Prophylactic Vs. Therapeutic Use of Uroxatrol to Determine Improvements in Urinary Morbidity Following Men Undergoing Prostate Brachytherapy[NCT00201630] | Phase 3 | 150 participants | Interventional | 2005-09-30 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 other studies available for alfuzosin and Cancer of Prostate
| Article | Year |
|---|---|
Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines.
Topics: Adrenergic alpha-1 Receptor Antagonists; Antineoplastic Agents; Apoptosis; Autophagy; Cell Death; Ce | 2016 |
High-grade prostate cancer and biochemical recurrence after radical prostatectomy among men using 5α-reductase inhibitors and alpha-blockers.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Cohort Studies; | 2013 |
Priapism as a possible acute side effect of radical radiotherapy for prostate cancer.
Topics: Adrenergic alpha-Antagonists; Aged; Humans; Male; Priapism; Prostate; Prostatic Neoplasms; Quinazoli | 2004 |
[The growth inhibition effect of alpha-adrenoceptor antagonists on androgen- independent prostate cancer cell line].
Topics: Adrenergic alpha-Antagonists; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Survival; Do | 2004 |
Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Algorithms; Androgen Antagonists; Anti-Bacterial Agents; | 2007 |
Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract.
Topics: Adenofibroma; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Cats; Decerebrate State; | 1993 |
[Comparison of selective alpha-1 blockades for alpha-receptors in human hypertrophied prostatic adenomas].
Topics: Adenoma; Adrenergic alpha-Antagonists; Aged; Humans; Male; Piperazines; Prazosin; Prostatic Hyperpla | 1992 |